| 05.02.17 | Healthcare’s future: Remote care, genomics and disease-sniffing robots

To view this email as a web page, click here

May 02, 2017 Subscribe Our Team Contact Us
FierceHealthcare-IT Logo  

Today’s Rundown

  1. Why data analytics, remote care and interconnectivity are prepared to transform medical care
  2. The robot will smell you now: Is odor analysis the next futuristic diagnostic tool?
  3. Oncologists are skeptical of genomics now but see a promising future
  4. New clinical decision support software guidelines highlight keys to self-regulation

Featured Story

Why data analytics, remote care and interconnectivity are prepared to transform medical care

Tuesday, May 2, 2017 As the healthcare industry turns to video conferencing, patient-generated data and modern communication tools, medical visits of the future will look vastly different than the current approach to care. Using smartphone applications and telehealth technology, medical care “will increasingly take place everywhere but the office," two healthcare futurists wrote in Fortune.

Top Stories

The robot will smell you now: Is odor analysis the next futuristic diagnostic tool?

Tuesday, May 2, 2017 Years from now, machines may be able to diagnose diseases like cancer simply by analyzing a patient’s smell. Several international companies are using analytics and artificial intelligence to create new diagnostic tools that can pinpoint diseases using odor analysis, according to The New York Times, and one expert says it’s a matter of years before the tools are introduced to the clinical environment.

Oncologists are skeptical of genomics now but see a promising future

Tuesday, May 2, 2017 Oncologists have a complicated relationship with genetic testing. Many see the emerging technology as impractical for patients, but they also recognize the impact genetic testing will have over the next decade. Approximately 7 in 10 oncologists believe genomic testing is very important or extremely important to oncology, but 55% also say genomic testing is overpromoted, according to a survey released by Medscape.

New clinical decision support software guidelines highlight keys to self-regulation

Tuesday, May 2, 2017 With the Food and Drug Administration adopting a limited role in regulating software that assists physicians with clinical decisions, a coalition of providers and developers released voluntary guidelines aimed at helping the industry self-regulate.

News of Note

Policymakers advocating a deregulated approach to health IT should look no further than the airline industry for some valuable lessons, wrote the CEO of PatientKeeper. Loosening industry oversight opened up opportunities for competition from startups like Southwest and JetBlue with innovative business models. Forbes op-ed EHR information entered by physicians is the first step to developing new products derived from a growing amount of health data, wrote David Blumenthal. Annals of Internal Medicine article Data analytics and technology are fueling a new age of compliance, said HHS Inspector General Dan Levinson. This data-driven approach has been a boon for fraud detection and enforcement. Health Data Management article Samsung’s CMO said he’s learned that improving patient engagement is a top priority for hospitals, and digital health could help address some of the biggest challenges facing healthcare today. MedCity News article


[Whitepaper] Preventing Hospital Readmissions and Improving Transitions of Care

Presented By: MCG MCG, part of the Hearst Health network and a leading provider of informed care strategies, offers a complimentary white paper download: Preventing Hospital Readmissions and Improving Transitions of Care by Angela Askren, RN, MSN, CNC.

[Whitepaper] Six gray areas of HIPAA you can’t ignore

Sponsored by: Scrypt This guide exists to shed some light on some of the ‘gray areas’ of HIPAA. This guide will help anyone concerned with HIPAA compliance gain a better understanding of the areas which may be a cause for confusion or concern.

[Whitepaper] Mobile health & HIPAA: Playing it safe in 2017

Sponsored by: Scrypt Is texting putting your business at risk for a HIPAA violation? The following steps are intended to help organizations appropriately manage the use of mobile devices in the healthcare setting.

[Webinar] Empowering Hospitals to Reduce Variability and Costs Through Automation and Analytics

Presented By: Cardinal Health During this free webinar, learn how RFID-enabled automation with data analytics is empowering hospitals to reduce variability and drive down costs.

[eBook] Managing Purchasing and Accounts in a Changing Provider Landscape

Sponsored By: American Express As providers continue to invest in new revenue opportunities, such as “microhospitals" and mergers, new challenges are presented. Download this eBook today to learn about best practices, and review case studies for managing today’s complex supply chain and accounts payable processes.

[Whitepaper] 5 Supply Chain Leader Traits and Why You Need Them to Survive in Today’s Evolving Healthcare Landscape

Presented By: Cardinal Health Industry trends like personalized medicine and healthcare consumerism are changing how care is delivered and received, which will continue challenging the healthcare supply chain. Download this complimentary Whitepaper to learn five traits that supply chain professionals must develop in order to succeed.  

[Whitepaper] The Paperless Future of Healthcare and Life Sciences

Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors.

[Whitepaper] DocuSign Life Sciences eBook: Reducing Cycle Time with Digital Transaction Management

Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more.

[Whitepaper] Streamline Regulatory Compliance in Life Sciences with Digital Transaction Management

Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company.



Posted in 未分類